ライフサイエンスコーパス: leucine-rich repeat

1 a central nucleotide binding and C-terminal leucine-rich repeats).

2 461, which are located on the convex face of leucine-rich repeats 16 and 17 of the mTLR4 ectodomain,

3 s nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 1 (NLRP1

4 me of Ewing and showed unexpectedly that the leucine-rich repeat and Ig domain protein 1 (LINGO1) is

5 Leucine-rich repeat and Ig-like domain-containing Nogo r

6 We previously demonstrated that leucine-rich repeat and Ig-like domain-containing Nogo r

7 LRIG1 (leucine-rich repeat and immunoglobulin-like domain conta

8 d nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain containing 3 (NRLP3

9 ng and oligomerization domain-like receptor, leucine-rich repeat and pyrin domain-containing 3 (NLRP3

10 nase kinases (MKKs) and rodent NLRP1B (NACHT leucine-rich repeat and pyrin domain-containing protein

11 the emerging concept that nucleotide-binding leucine-rich repeat and pyrin domain-containing receptor

12 lies are determined for the F-box-containing leucine-rich repeat and WD40 repeat families, but not fo

13 ng a high affinity interaction involving the leucine-rich repeats and a predicted lower affinity inte

14 large extracellular domain consisting of 10 leucine-rich repeats and an N-terminal low density lipop

15 ses an additional 33 amino acids between the leucine-rich repeats and carboxy-terminal low-complexity

16 Leucine-rich repeats and immunoglobulin-like domains 1 (

17 Here, we found that leucine-rich repeats and immunoglobulin-like domains 1 (

18 Leucine-rich repeats and immunoglobulin-like domains pro

19 es contained heparanase 1, heparanase 2, and leucine-rich repeats and immunoglobulin-like domains-2 (

20 domain of the NAIPs, rather than within the leucine-rich repeats, as was anticipated.

21 NLRs (nucleotide-binding domain and leucine-rich repeats) belong to a large family of cytopl

22 evious predictions of a chitinase domain and leucine-rich repeat but also revealed a putative carbohy

23 e substrate-binding domain of Dia2 comprises leucine-rich repeats, but Dia2 also has a TPR domain at

24 with the unstructured amino-terminal and the leucine-rich repeat carboxy-terminal domains of Tmod.

25 Both nucleotide-binding domain and leucine-rich repeat caspase recruitment domain 4 and nuc

26 a, encoding a coiled-coil nucleotide-binding leucine-rich repeat (CC-NB-LRR) protein.

27 long to the coiled-coil, nucleotide-binding, leucine-rich repeat class of intracellular immune recept

28 a dependent on nucleotide-binding domain and leucine rich repeat containing family, pyrin domain cont

29 e identify the nucleotide-binding domain and leucine rich repeat containing family, pyrin domain cont

30 Recently, several leucine-rich repeat containing (LRRC) proteins have been

31 mation through nucleotide-binding domain and leucine-rich repeat containing (NLRP3) inflammasome, whi

32 nical events except stroke, the LRRC3B gene (leucine-rich repeat containing 3B) with myocardial infar

33 Leucine-rich repeat containing 8A (LRRC8A) is an ubiquit

34 showing that multimers derived from LRRC8A (leucine-rich repeat containing 8A) gene are structural c

35 The nucleotide-binding domain and leucine-rich repeat containing family (NLR), pyrin domai

36 iversal beta-catenin target gene expression, leucine-rich repeat containing G protein-coupled recepto

37 Leucine-rich repeat containing G-protein-coupled recepto

38 tly characterized nucleotide-binding domain, leucine-rich repeat containing protein (NLR) that negati

39 Here, we report that leucine-rich repeat containing protein 25 (LRRC25) is a

40 he expression and physiological functions of leucine-rich repeat containing protein 26 (LRRC26) in ar

41 Nucleotide-binding domain and leucine-rich repeat containing PYD-3 (NLRP3) is a patter

42 re the role of the nucleotide-binding domain leucine-rich repeat containing receptor family member Nl

43 he role of the nucleotide-binding domain and leucine-rich repeat containing receptor NLRP10 in diseas

44 We recently identified leucine-rich repeat containing, G-protein-coupled recept

45 subfamily of NLR (nucleotide-binding domain, leucine-rich repeat containing, or NOD-like receptor) pr

46 (CITA), NLRC5 [nucleotide-binding domain and leucine-rich repeats containing (NLR) family, caspase ac

47 n VRACs was obtained by the discovery of the leucine-rich repeats containing 8A (LRRC8A) gene.

48 The nucleotide binding domain and leucine-rich repeat-containing (NLR) family of proteins

49 Leucine-rich repeat-containing 8 (LRRC8) proteins have b

50 In mice, specific nucleotide-binding domain, leucine-rich repeat-containing family, apoptosis inhibit

51 es include the nucleotide-binding domain and leucine-rich repeat-containing family, calcium channel s

52 IPs) activate the nucleotide-binding domain, leucine-rich repeat-containing family, CARD domain-conta

53 ndependent of the nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-cont

54 We show here that the orphan receptor leucine-rich repeat-containing G protein-coupled recepto

55 Here, we report on Lgr5 and Lgr6 (leucine-rich repeat-containing G protein-coupled recepto

56 eins and their cognate receptors, members of leucine-rich repeat-containing G protein-coupled recepto

57 s receptor, DLGR2, the ortholog of mammalian leucine-rich repeat-containing G protein-coupled recepto

58 Leucine-rich repeat-containing G protein-coupled recepto

59 , we report a pivotal role for the R-spondin/leucine-rich repeat-containing G protein-coupled recepto

60 rkers, epithelial cell adhesion molecule and leucine-rich repeat-containing G protein-coupled recepto

61 rapidly growing adenomas containing LGR5(+) (leucine-rich repeat-containing G-protein coupled recepto

62 g lineage tracing to mark cells derived from leucine-rich repeat-containing G-protein coupled recepto

63 R-spondins (RSPOs) and their receptor leucine-rich repeat-containing G-protein coupled recepto

64 ified Wnt environment leads to activation of leucine-rich repeat-containing G-protein coupled recepto

65 Leucine-rich repeat-containing G-protein coupled recepto

66 re we report that the abundant expression of leucine-rich repeat-containing G-protein-coupled recepto

67 duced inhibition of Wnt signaling depends on leucine-rich repeat-containing G-protein-coupled recepto

68 Leucine-rich repeat-containing G-protein-coupled recepto

69 ate that TLR4 induces ER stress within Lgr5 (leucine-rich repeat-containing G-protein-coupled recepto

70 Here we show that the leucine-rich repeat-containing G-protein-coupled recepto

71 Herein we report that leucine-rich repeat-containing G-protein-coupled recepto

72 The fourth member of the leucine-rich repeat-containing GPCR family (LGR4, freque

73 ) and conditional (Vil-CreER;Adam10(f/f) and Leucine-rich repeat-containing GPCR5 [Lgr5]-CreER;Adam10

74 o the B-family (or secretin-like), and 2 are leucine-rich repeat-containing GPCRs.

75 Nucleotide-binding domain, leucine-rich repeat-containing protein (NLR)P3 inflammas

76 cing mRNA expression of the BK gamma subunit leucine-rich repeat-containing protein 26 (LRRC26) and i

77 nted by a trait-associated SNP and encodes a leucine-rich repeat-containing protein.

78 are sensed by nucleotide binding domain and leucine-rich repeat-containing proteins (NLRs), which tr

79 a member of the LRIG family of transmembrane leucine-rich repeat-containing proteins, is a negative r

80 KINASE3, which is a key regulator of several leucine-rich repeat-containing PRRs.

81 d also affects stem cells, which express the leucine-rich repeat-containing receptor 5 (Lgr5).

82 eotide-binding oligomerization domain (Nod), leucine-rich repeat-containing receptors (NLRs), and pyr

83 otein of the NLR (nucleotide-binding domain, leucine-rich repeat-containing) superfamily or the PYHIN

84 creased glomerular nucleotide-binding domain leucine-rich repeat-containing-like receptor family, pyr

85 eceded presence of nucleotide-binding domain leucine-rich repeat-containing-like receptor family, pyr

86 , Epithelial cell adhesion molecule (EpCAM), Leucine-rich repeated-containing G-protein coupled recep

87 ng on the NLRX1 (nucleotide-binding, lots of leucine-rich repeats-containing protein member X1)-TUFM

88 Here we found that the nucleotide-binding, leucine-rich-repeat-containing protein, NLRC3, reduced S

89 tor (TLR) and nucleotide-binding domain- and leucine-rich-repeat-containing receptor (NLR) pathway ge

90 activation of the nucleotide-binding domain, leucine-rich-repeat-containing receptor (NLR), pyrin-dom

91 1 component (S519C16) of S519 with the first leucine-rich repeat domain (L1) of the insulin receptor.

92 alpha dissociation and unfolds the GPIbalpha leucine-rich repeat domain (LRRD) and juxtamembrane mech

93 Scribble consists of a leucine-rich repeat domain and four PDZ domains, with th

94 through two identified binding sites in its leucine-rich repeat domain and regulating collagen fibri

95 The tyrosine-sulfated domain and the leucine-rich repeat domain both bound to three specific

96 The isolated leucine-rich repeat domain inhibited the fibril formatio

97 flammasome required NEK7, which bound to the leucine-rich repeat domain of NLRP3 in a kinase-independ

98 otide binding oligomerization domain and the leucine-rich repeat domain of NLRP3 were the intracellul

99 ocytes, GPSM3 associates with the C-terminal leucine-rich repeat domain of NLRP3.

100 The leucine-rich repeat domain of PP32 is composed of five b

101 This work demonstrates that changes in the leucine-rich repeat domain of the TIR1 auxin coreceptor

102 They are composed of an extracellular leucine-rich repeat domain responsible for detecting pat

103 domain gene product containing an N-terminal leucine-rich repeat domain, followed by a likely posttra

104 e plant can evolve nucleotide-binding domain-leucine-rich repeat domain-containing proteins to recogn

105 Finally, we find that the Prf leucine-rich repeats domain also binds the N-terminal re

106 Proteins with nucleotide binding and leucine-rich repeat domains (NLRs) serve as immune recep

107 transmembrane proteins characterized by six leucine-rich repeat domains and one immunoglobulin-like

108 g because the N-terminal Pyrin or C-terminal leucine-rich repeat domains were dispensable.

109 Moreover, the leucine-rich repeat domains, and specifically four amino

110 Chondroadherin, a leucine-rich repeat family member, contains a very C-ter

111 tf13, defining it as an F-box protein of the leucine-rich-repeat family, and demonstrates how a novel

112 We show that Drosophila leucine-rich repeat G protein-coupled receptor 3 (Lgr3)

113 th rapidly expanding nucleotide-binding site-leucine-rich repeat gene families.

114 coccum is a coiled-coil, nucleotide-binding, leucine-rich repeat gene that confers near immunity to U

115 RenSeq is a NB-LRR (nucleotide binding-site leucine-rich repeat) gene-targeted, Resistance gene enri

116 inct protein domains, including glycosidase, leucine-rich repeat, hybrid Ig, carbohydrate binding mod

117 The Leucine rich repeat kinase 2 (LRRK2) gene is genetically

118 Leucine rich repeat kinase 2 (LRRK2) has been geneticall

119 Leucine rich repeat kinase 2 is a complex enzyme with bo

120 Here, we show that Leucine-rich repeat kinase (Lrrk), the Drosophila melano

121 The leucine-rich repeat kinase (LRRK)-2 protein contains non

122 Our studies identify leucine-rich repeat kinase 1 (LRRK1), a key regulator of

123 Mutations in leucine-rich repeat kinase 2 (LRRK2) and alpha-synuclein

124 Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause

125 Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are a common geneti

126 Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with

127 Mutations in leucine-rich repeat kinase 2 (LRRK2) are common causes o

128 Mutations in leucine-rich repeat kinase 2 (LRRK2) are found in a sign

129 Mutations in leucine-rich repeat kinase 2 (Lrrk2) are the most common

130 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

131 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

132 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

133 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most freque

134 Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) can cause Parkinson

135 Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dom

136 Mutations in leucine-rich repeat kinase 2 (LRRK2) cause inherited Par

137 Mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset, a

138 Mutations in leucine-rich repeat kinase 2 (LRRK2) contribute to devel

139 Mutations in the kinase domain of leucine-rich repeat kinase 2 (LRRK2) follow Parkinson's

140 Although the Leucine-rich repeat kinase 2 (LRRK2) G2019S missense mut

141 Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most c

142 Missense mutations in the leucine-rich repeat kinase 2 (LRRK2) gene can cause late

143 Genetic variation in the leucine-rich repeat kinase 2 (LRRK2) gene is associated

144 Leucine-rich repeat kinase 2 (LRRK2) has been associated

145 Parkinson's disease gene leucine-rich repeat kinase 2 (LRRK2) has been implicated

146 Leucine-rich repeat kinase 2 (LRRK2) has been linked to

147 Leucine-rich repeat kinase 2 (LRRK2) has drawn significa

148 Multiple missense mutations in Leucine-rich repeat kinase 2 (LRRK2) have been linked to

149 emical studies implicate alpha-synuclein and leucine-rich repeat kinase 2 (LRRK2) in late-onset PD.

150 Leucine-rich repeat kinase 2 (LRRK2) is a large, multido

151 Leucine-rich repeat kinase 2 (LRRK2) is a large, multido

152 Leucine-rich repeat kinase 2 (LRRK2) is a multi-domain e

153 Leucine-rich repeat kinase 2 (LRRK2) is a multidomain pr

154 Leucine-rich repeat kinase 2 (LRRK2) is enriched in the

155 Leucine-rich repeat kinase 2 (LRRK2) is the single most

156 Mutations in leucine-rich repeat kinase 2 (LRRK2) lead to late-onset,

157 Leucine-rich repeat kinase 2 (LRRK2) mutation 6055G-->A

158 The effect of leucine-rich repeat kinase 2 (LRRK2) mutation I2020T on

159 Leucine-rich repeat kinase 2 (LRRK2) mutations are the m

160 The leucine-rich repeat kinase 2 (LRRK2) protein has been ge

161 tions in Park8, encoding for the multidomain Leucine-rich repeat kinase 2 (LRRK2) protein, comprise t

162 issue of Cell, Martin et al. link PD protein leucine-rich repeat kinase 2 (LRRK2) to abnormalities of

163 LRRK2, encoding the multifunctional protein leucine-rich repeat kinase 2 (LRRK2), are a common cause

164 nes linked to genetic forms of PD, including leucine-rich repeat kinase 2 (LRRK2), functionally conve

165 unknown, but several genetic loci, including leucine-rich repeat kinase 2 (LRRK2), have been identifi

166 ociated gene for leucine-rich repeat kinase, leucine-rich repeat kinase 2 (LRRK2), is highly expresse

167 Mutations in leucine-rich repeat kinase 2 (LRRK2), such as G2019S, ar

168 encoding a-synuclein (SNCA), tau (MAPT), and leucine-rich repeat kinase 2 (LRRK2).

169 se of Parkinson's disease (PD), mutations in leucine-rich repeat kinase 2 (LRRK2).

170 al effects of a common PD-linked mutation of leucine-rich repeat kinase 2 in the mouse hippocampus, a

171 LRRK2 (leucine-rich repeat kinase) mutations constitute the mos

172 a WRKY10 transcription factor) and HAIKU2 (a leucine-rich repeat kinase).

173 The common PD-associated gene for leucine-rich repeat kinase, leucine-rich repeat kinase 2

174 Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosoma

175 Mutation in leucine-rich-repeat kinase 2 (LRRK2) is a common cause o

176 st these factors using mutant LRRK2(R1441G) (leucine-rich-repeat-kinase-2) knockin mice.

177 Alpha-synuclein (SNCA) and Leucine-rich repeat kinase2 (LRRK2) have been implicated

178 On examples of proteins with Leucine Rich Repeat (LRR) domains and other solenoids li

179 most N-terminal domain of Reck binds to the leucine-rich repeat (LRR) and immunoglobulin (Ig) domain

180 Here, the properties of a leucine-rich repeat (LRR) domain protein, designated Adp

181 is repressed by a flanking substrate-binding leucine-rich repeat (LRR) domain when substrate is absen

182 The ECD is divided into two leucine-rich repeat (LRR) domains, each of which is capp

183 ly (IgSF), fibronectin type III (FnIII), and leucine-rich repeat (LRR) families, which are known to b

184 CCR4s contain N-terminal leucine-rich repeat (LRR) motifs that interact with CAF1

185 port isolation and identification of a novel Leucine-Rich Repeat (LRR) protein that directly interact

186 s a coiled-coil (CC)-nucleotide-binding (NB)-leucine-rich repeat (LRR) protein.

187 Transmembrane leucine-rich repeat (LRR) receptors are commonly used in

188 3 (CLV3), and its perception by cell surface leucine-rich repeat (LRR) receptors, including the CLV1

189 mutants encodes a receptor lacking a single leucine-rich repeat (LRR) within its N-terminus.

190 a ubiquitously expressed gene that encodes a leucine-rich repeat (LRR)-containing protein detected at

191 his study, we identified LRRC25, a member of leucine-rich repeat (LRR)-containing protein family, as

192 r that developing and mature HCs express the leucine-rich repeat (LRR)-containing protein netrin-G li

193 After ligand perception, many leucine-rich repeat (LRR)-containing PRRs interact with

194 eotide-binding (NB) domain, and a C-terminal leucine-rich repeat (LRR).

195 NLRs (nucleotide-binding domain [NBD] leucine-rich repeat [LRR]-containing proteins) exhibit d

196 NLR (nucleotide-binding domain [NBD]- and leucine-rich repeat [LRR]-containing) proteins mediate i

197 scaffold protein composed almost entirely by leucine-rich repeats (LRRs) and having an N-terminal reg

198 d cytoplasmic protein that contains multiple leucine-rich repeats (LRRs) and interacts with integrin-

199 c screen for genes encoding proteins bearing leucine-rich repeats (LRRs) and nucleotide-binding domai

200 usly expressed transmembrane protein with 17 leucine-rich repeats (LRRs) at its C-terminal end and is

201 vo design of capping structures, we designed leucine-rich repeats (LRRs) from the ribonuclease inhibi

202 ained interaction between A1 and the central leucine-rich repeats (LRRs) of GPIbalpha, previously sho

203 idues on the concave surfaces of neighboring leucine-rich repeat modules assists in stabilizing the o

204 ition, plants use the nucleotide-binding and leucine-rich repeat (NB-LRR) domain-containing resistanc

205 Several plant nucleotide-binding, leucine-rich repeat (NB-LRR) immune receptors carry fusi

206 Nucleotide-binding leucine-rich repeat (NB-LRR, or NLR) receptors mediate p

207 The cytosolic nucleotide binding site-leucine rich repeat (NBS-LRR) resistance proteins of pla

208 eceptors belonging to the nucleotide-binding leucine-rich repeat (NLR) family.

209 by members of the nucleotide binding domain leucine-rich repeat (NLR) protein family that respond to

210 ition of XopQ 1 (Roq1), a nucleotide-binding leucine-rich repeat (NLR) protein with a Toll-like inter

211 ical to VICTR, encoding a nucleotide-binding leucine-rich repeat (NLR) protein(3).

212 med RPS5, which encodes a nucleotide-binding leucine-rich repeat (NLR) protein.

213 Nucleotide-binding domain and leucine-rich repeat (NLR) proteins are a diverse family

214 Nucleotide-binding domain and leucine-rich repeat (NLR) proteins are well-known for th

215 Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable cells to respo

216 Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable plants to reco

217 Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable the immune sys

218 Nucleotide-binding domain leucine-rich repeat (NLR) proteins function as cytosolic

219 stance genes encoding for nucleotide-binding leucine-rich repeat (NLR) proteins hampers their predict

220 Nucleotide-binding leucine-rich repeat (NLR) proteins serve as immune recep

221 ted by intracellular nucleotide-binding site leucine-rich repeat (NLR) receptor proteins.

222 Intracellular nucleotide-binding leucine-rich repeat (NLR) receptors play central roles i

223 r proteins of the nucleotide-binding domain, leucine-rich repeat (NLR) superfamily to detect many typ

224 OUS MIX2 (DM2) nucleotide-binding domain and leucine-rich repeat (NLR)-encoding locus in A. thaliana.

225 ique among the nucleotide-binding-domain and leucine-rich-repeat (NLR) proteins in its mitochondrial

226 rs designated "nucleotide-binding domain and leucine-rich repeat" (NLR) proteins that translate patho

227 overexpression down-regulated PH domain and leucine-rich repeat phosphatase (PHLPP) and that PHLPP o

228 Pleckstrin homology domain and leucine rich repeat protein phosphatase 1 (PHLPP1) is a

229 hibit caspase-1 activation by the NLR family leucine-rich repeat protein (NLRP)1 and NLRP3 inflammaso

230 r matrix component proline/arginine-rich end leucine-rich repeat protein (PRELP) is a novel antibacte

231 he EMT inducer Twist1 by enhancing F-box and leucine-rich repeat protein 14 (FBXL14)-mediated polyubi

232 Here, we show that Fbxl17 (F-box and leucine-rich repeat protein 17) targets Sufu for proteol

233 ulators, casein kinase 1 (CKI) and F-box and leucine-rich repeat protein 3 (FBXL3), modulate the stab

234 is capable of triggering NLRP3 (NLR-family, leucine-rich repeat protein 3) inflammasome activation a

235 The hemerythrin-like domain of F-box and leucine-rich repeat protein 5 (FBXL5), an E3 ubiquitin l

236 te that reovirus binds Nogo receptor NgR1, a leucine-rich repeat protein expressed in the CNS, to inf

237 usly unrecognized role for the transmembrane leucine-rich repeat protein Lapsyn in regulating mng dev

238 We show that the phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP) downstre

239 we show that the pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP) suppress

240 n this study, we demonstrated that PH domain leucine-rich repeat protein phosphatase (PHLPP), a novel

241 we identified pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1) as a

242 tion of two splice variants of PH domain and Leucine-rich repeat Protein Phosphatase 1 (PHLPP1), PHLP

243 co-localization of Akt and PHLPP1 (PH domain leucine-rich repeat protein phosphatase isoform 1), a Se

244 tase PHLPP1 (pleckstrin homology (PH) domain leucine-rich repeat protein phosphatase) to Akt.

245 tion of the translation of the PH domain and leucine-rich repeat protein phosphatases 1 (PHLPP1), a p

246 1.2 encodes a coiled-coil nucleotide-binding leucine-rich repeat protein that in addition to potato a

247 rice gene Xa1, encoding a nucleotide-binding leucine-rich repeat protein, confers resistance against

248 Surprisingly, a single transmembrane leucine-rich repeat protein, DMA-1, plays a major role i

249 c map of the entire folding landscape of the leucine-rich repeat protein, pp32 (Anp32), obtained by c

250 complex, composed of the nucleotide-binding leucine-rich repeats protein Prf and the protein kinase

251 resistance genes encoding nucleotide binding-leucine rich repeat proteins and genes encoding pentatri

252 Nucleotide binding domain and leucine-rich repeat proteins (NLRs) are important recept

253 Nucleotide-binding leucine-rich repeat proteins (NLRs) serve as intracellul

254 proteins interacted with nucleotide binding-leucine-rich repeat proteins and effector proteins, sugg

255 enes encoding coiled-coil nucleotide-binding leucine-rich repeat proteins designated CNL3 and CNL13.

256 Variable lymphocyte receptors (VLRs) are leucine-rich repeat proteins that mediate adaptive immun

257 s in the expansion of nucleotide-binding and leucine-rich-repeat proteins (NLRs), the major disease-r

258 Small leucine-rich repeat proteoglycan (SLRP) family proteins

259 The mouse nucleotide-binding domain and leucine rich repeat pyrin containing 1b (NLRP1b) inflamm

260 t domain 4 and nucleotide-binding domain and leucine-rich repeat pyrin domain 3 are simultaneously pr

261 ulators of the nucleotide-binding domain and leucine-rich repeat pyrin domain containing 3 inflammaso

262 and activate the nucleotide-binding domain, leucine-rich repeat pyrin domain-containing 3 (NLRP3) in

263 1 does so via the nucleotide-binding domain, leucine-rich repeat, pyrin domain containing protein 3 (

264 NLR, nucleotide binding and oligomerization, leucine-rich repeat, pyrin domain-containing 3 (NLRP3),

265 es with pyrin and nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing 3.

266 endocytosis of transferrin, FM-4-64, and the leucine rich repeat receptor like protein LeEix2, an eff

267 ovo assembly of complete nucleotide-binding, leucine-rich repeat receptor (NLR) genes, their regulato

268 patterns by a nucleotide-binding domain and leucine-rich repeat receptor (NLR) or absent in melanoma

269 Floral abscission is controlled by the leucine-rich repeat receptor kinase (LRR-RK) HAESA and t

270 Phytosulfokine (PSK) is perceived by the leucine-rich repeat receptor kinase PSKR1 and promotes g

271 by direct binding to the membrane-localized leucine-rich repeat receptor kinases, PEP RECEPTOR1 (PEP

272 termined that BAM1, which is a member of the leucine-rich repeat receptor-like kinase (LRR-RLK) famil

273 that the constitutive activation of NIK1, a leucine-rich repeat receptor-like kinase (LRR-RLK) ident

274 d resistance to GPA that is dependent on the leucine-rich repeat receptor-like kinase BRASSINOSTEROID

275 roid insensitive 1 (BRI1) is a member of the leucine-rich repeat receptor-like kinase family.

276 SR-related) peptides and the CLAVATA1 (CLV1) leucine-rich repeat receptor-like kinase is expressed in

277 n of the plasma membrane-localized, atypical leucine-rich repeat receptor-like kinase POLLEN-SPECIFIC

278 d to a shoot receptor complex containing the leucine-rich repeat receptor-like kinase SUNN, triggerin

279 liana plant architecture, ERECTA, encoding a leucine-rich repeat receptor-like kinase.

280 Leucine-rich repeat receptor-like kinases (LRR RLKs) for

281 st to G protein activation in animals, plant leucine-rich repeat receptor-like kinases (LRR RLKs), no

282 nases expanded massively in land plants, and leucine-rich repeat receptor-like kinases (LRR-RLK) cons

283 , mitogen-activated protein kinases (MAPKs), leucine-rich repeat receptor-like kinases (LRR-RLKs) and

284 Cell signaling pathways mediated by leucine-rich repeat receptor-like kinases (LRR-RLKs) are

285 the CLE family interacting with CLAVATA1 and leucine-rich repeat receptor-like kinases (LRR-RLKs).

286 d BAK1(SERK3) in the natural habitat of both leucine-rich repeat receptor-like kinases using comparat

287 hamiana, which also involves the Arabidopsis leucine-rich repeat receptor-like protein SOBIR1 (for SU

288 BPG1), an Arabidopsis (Arabidopsis thaliana) leucine-rich repeat receptor-like protein, AtRLP42, that

289 Pangloss1 (PAN1) and PAN2 are leucine-rich repeat receptor-like proteins that function

290 Here we report FASCIATED EAR3 (FEA3), a leucine-rich-repeat receptor that functions in stem cell

291 i, including proteins putatively involved in leucine-rich repeat recognition activity, second messeng

292 Nucleotide-binding site leucine-rich repeat resistance genes (NLRs) allow plants

293 Shoc2 is a leucine-rich repeat scaffold protein that acts as a posi

294 ike mechanism that employs flanking variable leucine-rich repeat sequences as templates in associatio

295 PR library targeting the immunity-associated leucine-rich repeat subfamily XII genes, heritable mutat

296 e that cooperativity requires the N-terminal leucine-rich repeat-targeting domain and is transduced t

297 ules neurexin-1beta, neuroligin-1 (Nlg1) and leucine-rich-repeat transmembrane protein 2 (LRRTM2) in

298 TLR4 interactor with leucine-rich repeats (TRIL) is a brain-enriched accessor

299 LAT); B-cell CLL/lymphoma 11B (BCL11B); RGD, leucine-rich repeat, tropomodulin domain, and proline-ri

300 hocyte receptors (VLRs) composed of variable leucine-rich repeats, which are differentially expressed